Form 4: Fulgent Genetics President and COO Sells Shares to Cover Tax Obligations

Jian Xie, President and COO of Fulgent Genetics, sold 715 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Summary

• On August 27, 2024, Jian Xie, the President and COO of Fulgent Genetics, sold 715 shares of Fulgent Genetics (FLGT) common stock.
• The sale was executed at a weighted-average price of $22.833 per share, with individual transactions ranging from $22.72 to $22.915.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 23, 2023.
• Following the transaction, Mr. Xie directly owns 342,764 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.
• Mr. Xie serves on the investment committee of the Trust and disclaims beneficial interest except for any pecuniary interest.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

This is a routine Form 4 filing related to an insider transaction. It is common for executives to sell shares to cover tax obligations when restricted stock units vest. The sale itself is unlikely to have a significant impact on the company's overall performance or stock price.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but is unlikely to be significant.

Key Dates